Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological approaches for HIV therapy.

F Lori1, L M Kelly, J Lisziewicz

  • 1Research Institute for Genetic and Human Therapy, at IRCCS Policlinico S. Matteo, Pavia, Italy. rightpv@tin.it

Current Drug Targets. Infectious Disorders
|May 29, 2003
PubMed
Summary

Developing effective Human Immunodeficiency Virus (HIV) vaccines requires inducing a Th-1 immune response. DNA vaccines offer a promising strategy, with advancements enabling rational design and improved immunogenicity through adjuvants and optimized delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.

Gene therapy·2014
Same author

Rapid on-site evaluation of axillary fine-needle aspiration cytology in breast cancer.

The British journal of surgery·2012
Same author

Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.

Vaccine·2011
Same author

Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in [corrected] HIV/AIDS.

British journal of pharmacology·2010
Same author

Nanochemistry-based immunotherapy for HIV-1.

Current medicinal chemistry·2007
Same author

Changing patterns of thyroid carcinoma.

Irish journal of medical science·2007

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • A Th-1 polarized immune response is crucial for effective Human Immunodeficiency Virus (HIV) therapy.
  • DNA vaccines are a leading strategy for inducing Th-1 responses.
  • Rational vaccine design is now feasible based on experimental data.

Purpose of the Study:

  • To review recent advances in preventive and therapeutic HIV vaccines.
  • To evaluate the benefits and risks of novel vaccine strategies for HIV-infected individuals.
  • To introduce the concept of "autovaccination" and its application in antigen-presenting cell-targeted HIV vaccines.

Main Methods:

  • Systematic review of recently developed HIV vaccines.
  • Evaluation of vaccine design factors: immunogens, adjuvants, administration routes, and prime/boost schedules.

Related Experiment Videos

  • Definition and application of the "autovaccination" concept.

    • Main Results:

    • DNA vaccines can be rationally designed to enhance immunogenicity.
    • Adjuvants can modulate immune response polarization and increase immunogenicity.
    • DermaVir, a topical vaccine, showed immunological and clinical benefits in a rhesus macaque model when combined with antiretroviral therapy.

    Conclusions:

    • Optimized vaccine design, including adjuvant selection and administration strategies, is key for successful HIV immunotherapies.
    • "Autovaccination" provides a basis for innovative therapeutic vaccines.
    • DermaVir represents a novel topical vaccine approach with demonstrated efficacy in preclinical models.